Mianli Bian , Junyang Ji , Naqi Lian , Yongjie Li , Weijie Zhu , Peng Cao , Feng Zhang
{"title":"Glycyrrhetinic acid orchestrates ERS-pyroptosis crosstalk to elicit immunogenic cell death in hepatocellular carcinoma","authors":"Mianli Bian , Junyang Ji , Naqi Lian , Yongjie Li , Weijie Zhu , Peng Cao , Feng Zhang","doi":"10.1016/j.phymed.2025.157309","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Hepatocellular carcinoma (HCC) remains a magnitude global public health challenges since its aggressive biological behavior and persistently high morbidity and mortality rates. Glycyrrhetinic acid (GA), a bioactive triterpenoid extracted from Glycyrrhiza glabra, has been reported in certain contexts to suppress HCC cell migration and proliferation. In addition, the markedly immunosuppressive tumor microenvironment of HCC represents a major obstacle to achieving durable responses with immunotherapy.</div></div><div><h3>Purpose</h3><div>This study focused on elucidating the anti-hepatoma activity of GA, uncover the underlying molecular pathways, and assess its ability to trigger immunogenic cell death (ICD) as a potential therapeutic strategy for HCC.</div></div><div><h3>Methods</h3><div>Tumor-suppressive effects of GA were evaluated through histopathological analysis in multiple murine models, including cell line-derived xenografts (CDX), orthotopic liver implantation, and lung metastasis models. Transmission electron microscopy (TEM), intracellular calcium (Ca<sup>2+</sup>) assays, ROS staining, and immunofluorescence were used to investigate GA-induced endoplasmic reticulum stress (ERS) and pyroptosis in HCC cells. Proteomics and transcriptomics were applied to profile changes in protein and transcript expression. CETSA, DARTS, pull-down and molecular docking were employed to identify the direct molecular target of GA.</div></div><div><h3>Results</h3><div>The studies suggested that GA exhibited considerably similar anticancer efficacy (IRT = 46.62 %) compared with DOX (IRT = 48.87 %) in a CDX mouse model. Additionally, GA robustly activated ERS via PERK signaling and induced GSDME-mediated pyroptosis, increasing the cytoplasmic Ca<sup>2+</sup> concentration, driving the translocation of calreticulin (83.32 %) to the tumor cell surface, resulting in the strong release of proinflammatory cytokines and immunogenic signals. This coordinated interaction enhanced DC maturation and T-cell dependent adaptive immune responses, amplifying antitumor immunity.</div></div><div><h3>Conclusion</h3><div>Our findings highlight a novel mechanism whereby GA exploits the ERS-pyroptosis axis to potentiate ICD and amplify antitumor immunity in HCC, providing mechanistic insight and potential therapeutic implications.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"148 ","pages":"Article 157309"},"PeriodicalIF":8.3000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytomedicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0944711325009353","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Hepatocellular carcinoma (HCC) remains a magnitude global public health challenges since its aggressive biological behavior and persistently high morbidity and mortality rates. Glycyrrhetinic acid (GA), a bioactive triterpenoid extracted from Glycyrrhiza glabra, has been reported in certain contexts to suppress HCC cell migration and proliferation. In addition, the markedly immunosuppressive tumor microenvironment of HCC represents a major obstacle to achieving durable responses with immunotherapy.
Purpose
This study focused on elucidating the anti-hepatoma activity of GA, uncover the underlying molecular pathways, and assess its ability to trigger immunogenic cell death (ICD) as a potential therapeutic strategy for HCC.
Methods
Tumor-suppressive effects of GA were evaluated through histopathological analysis in multiple murine models, including cell line-derived xenografts (CDX), orthotopic liver implantation, and lung metastasis models. Transmission electron microscopy (TEM), intracellular calcium (Ca2+) assays, ROS staining, and immunofluorescence were used to investigate GA-induced endoplasmic reticulum stress (ERS) and pyroptosis in HCC cells. Proteomics and transcriptomics were applied to profile changes in protein and transcript expression. CETSA, DARTS, pull-down and molecular docking were employed to identify the direct molecular target of GA.
Results
The studies suggested that GA exhibited considerably similar anticancer efficacy (IRT = 46.62 %) compared with DOX (IRT = 48.87 %) in a CDX mouse model. Additionally, GA robustly activated ERS via PERK signaling and induced GSDME-mediated pyroptosis, increasing the cytoplasmic Ca2+ concentration, driving the translocation of calreticulin (83.32 %) to the tumor cell surface, resulting in the strong release of proinflammatory cytokines and immunogenic signals. This coordinated interaction enhanced DC maturation and T-cell dependent adaptive immune responses, amplifying antitumor immunity.
Conclusion
Our findings highlight a novel mechanism whereby GA exploits the ERS-pyroptosis axis to potentiate ICD and amplify antitumor immunity in HCC, providing mechanistic insight and potential therapeutic implications.
期刊介绍:
Phytomedicine is a therapy-oriented journal that publishes innovative studies on the efficacy, safety, quality, and mechanisms of action of specified plant extracts, phytopharmaceuticals, and their isolated constituents. This includes clinical, pharmacological, pharmacokinetic, and toxicological studies of herbal medicinal products, preparations, and purified compounds with defined and consistent quality, ensuring reproducible pharmacological activity. Founded in 1994, Phytomedicine aims to focus and stimulate research in this field and establish internationally accepted scientific standards for pharmacological studies, proof of clinical efficacy, and safety of phytomedicines.